Brennan, Paul

Dr

  • 2 Citations
  • 1 h-Index
20172019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Hematoma, Subdural, Chronic Medicine & Life Sciences
Hepatitis Medicine & Life Sciences
Methylprednisolone Medicine & Life Sciences
Colitis Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Hepatitis B Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

  • 2 Citations
  • 1 h-Index
  • 5 Article
  • 2 Letter
  • 1 Editorial
  • 1 Review article
6 Downloads (Pure)

Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase

Edlmann, E., Thelin, E. P., Caldwell, K., Turner, C., Whitfield, P., Bulters, D., Holton, P., Suttner, N., Owusu-Agyemang, K., Al-Tamimi, Y. Z., Gatt, D., Thomson, S., Anderson, I. A., Richards, O., Gherle, M., Toman, E., Nandi, D., Kane, P., Pantaleo, B., Davis-Wilkie, C. & 13 othersTarantino, S., Barton, G., Marcus, H. J., Chari, A., Belli, A., Bond, S., Gafoor, R., Dawson, S., Whitehead, L., Brennan, P., Wilkinson, I., Kolias, A. G. & Hutchinson, P. J. A., 10 Apr 2019, In : Scientific Reports. 9, p. 1-13 13 p., 5885.

Research output: Contribution to journalArticle

Open Access
File
Hematoma, Subdural, Chronic
Dexamethasone
Randomized Controlled Trials
Placebos
Outcome Assessment (Health Care)

New Horizons in Hepatitis B and C in the Older Adult

Kemp, L., Clare, K. E., Brennan, P. N. & Dillon, J. F., 1 Jan 2019, In : Age and Ageing. 48, 1, p. 32-37 6 p., afy170.

Research output: Contribution to journalArticle

Hepatitis C
Hepatitis B
Sexual Partners
Infection
Viruses
9 Downloads (Pure)

Nivolumab and immune-mediated colitis

Walker, H., Brennan, P., Groome, M., Walsh, S. & Carey, F., 8 Apr 2019, In : Clinical Case Reports. 7, 4, p. 644-647 4 p.

Research output: Contribution to journalArticle

Open Access
File
Methylprednisolone
Colitis
Hospitalization
Therapeutics
nivolumab

Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort

Plevris, N., Chuah, C. S., Allen, R. M., Arnott, I. D., Brennan, P. N., Chaudhary, S., Churchhouse, A. M. D., Din, S., Donoghue, E., Gaya, D. R., Groome, M., Jafferbhoy, H. M., Jenkinson, P. W., Lam, W. L., Lyons, M., Macdonald, J. C., MacMaster, M., Mowat, C., Naismith, G. D., Potts, L. F. & 11 othersSaffouri, E., Seenan, J. P., Sengupta, A., Shasi, P., Sutherland, D. I., Todd, J. A., Veryan, J., Watson, A. J. M., Watts, D., Jones, G. R. & Lees, C. W., 14 Feb 2019, In : Journal of Crohn's and Colitis. 37 p.

Research output: Contribution to journalArticle

Ulcerative Colitis
Inflammatory Bowel Diseases
Crohn Disease
Safety
Leukocyte L1 Antigen Complex

Acute liver failure of indeterminate aetiology: Authors’ reply

Brennan, P. N., Donnelly, M. C. & Simpson, K. J., Nov 2018, In : Alimentary Pharmacology & Therapeutics. 48, 9, p. 1025-1026 2 p.

Research output: Contribution to journalLetter